prikaz prve stranice dokumenta Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation
  Preuzmi
PDF 382.8 KB
Stručni rad - Stručni rad
Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation
Medicine, 100 (2021), 2; e23975. https://doi.org/10.1097/MD.0000000000023975
Premužić, Vedran; Stevanović, Ranko; Radić, Petra; Salvetti, Massimo; Lovrić-Benčić, Martina; Jelaković, Ana; Miličić, Davor; Capak, Krunoslav; Agabiti-Rosei, Enrico; Jelaković, Bojan

Citiranost:
,
Citirajte ovaj rad

Premužić, V., Stevanović, R., Radić, P., Salvetti, M., Lovrić Benčić, M., Jelaković, A. ... Jelaković, B. (2021). Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation. Medicine, 100. (2). doi: 10.1097/MD.0000000000023975

Premužić, Vedran, et al. "Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation." Medicine, vol. 100, br. 2, 2021. https://doi.org/10.1097/MD.0000000000023975

Premužić, Vedran, Ranko Stevanović, Petra Radić, Massimo Salvetti, Martina Lovrić Benčić, Ana Jelaković, Davor Miličić, Krunoslav Capak, Enrico Agabiti Rosei i Bojan Jelaković. "Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation." Medicine 100, br. 2 (2021). https://doi.org/10.1097/MD.0000000000023975

Premužić, V., et al. (2021) 'Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation', Medicine, 100(2). doi: 10.1097/MD.0000000000023975

Premužić V, Stevanović R, Radić P, Salvetti M, Lovrić Benčić M, Jelaković A, i sur.. Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation. Medicine [Internet]. 15.01.2021. [pristupljeno 22.02.2025.];100(2). doi: 10.1097/MD.0000000000023975

V. Premužić, et al., "Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation", Medicine, vol. 100, br. 2, Siječanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:253129. [Citirano: 22.02.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:253129
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation
AutorVedran Premužić
AutorRanko Stevanović
AutorPetra Radić
AutorMassimo Salvetti
AutorMartina Lovrić-Benčić
AutorAna Jelaković
AutorDavor Miličić
AutorKrunoslav Capak
AutorEnrico Agabiti-Rosei
AutorBojan Jelaković
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (hrvatski)
Our aim was to analyze characteristics of atrial fibrillation (AF) patients with chronic kidney disease (CKD) from the Croatian cohort of the ESH A Fib survey and to determine the association of estimated glomerular filtration rate (eGFR) with cardiovascular (CV) mortality after 24 months of follow-up.Consecutive sample of 301 patients with AF were enrolled in the period 2014 to 2018. Hypertension was defined as BP > 140/90 mm Hg and/or antihypertensive drugs treatment, CKD was defined as... Više eGFR (CKD Epi) < 60 ml/min/1.73 m2 which was confirmed after 3 months.CKD was diagnosed in 45.2% of patients (13.3% in CKD stage > 3b). CKD patients were older than non-CKD and had significantly more frequent coronary heart disease, heart failure and valvular disease. CKD patients had significantly higher CHA2DS2-VASc score and more CKD than non-CKD patients had CHA2DS2-VASc > 2. Crude CV mortality rate per 1000 population at the end of the first year of the follow-up was significantly higher in CKD vs non-CKD group who had shorter mean survival time. CV mortality was independently associated with eGFR, male gender, CHA2DS2VASc and R2CHA2DS2VASc scores.Prevalence of CKD, particularly more advanced stages of CKD, is very high in patients with AF. Observed higher CV mortality and shorter mean survival time in CKD patients could be explained with higher CHA2DS2VASc score which is a consequence of clustering of all score components in CKD patients. However, eGFR was independently associated with CV mortality. In our cohort, R2CHA2DS2VASc score was not associated significantly more with CV mortality than CHA2DS2VASc score. Sakrij dio sažetka
Ključne riječi (hrvatski)
Jezikengleski
Vrsta publikacijeStručni rad - Stručni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMedicine
Brojčani podacivol. 100, br. 2, e23975
p-ISSN0025-7974
e-ISSN1536-5964
DOIhttps://doi.org/10.1097/MD.0000000000023975
URN:NBNurn:nbn:hr:105:253129
Datum objave publikacije2021-01-15
URL dokumentahttps://journals.lww.com/10.1097/MD.0000000000023975
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2021-07-06 10:09:46
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.